Fig. 7From: Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiotaStool from BBR treated mice suppressed colorectal carcinogenesis in an AOM/DSS mouse model. A-B Western blot analysis showing the β-catenin and PCNA expression of colon tissue among groups. Data are expressed as mean ± SD (*P < 0.05, **P < 0.01)Back to article page